Covid-19: Impact of No-deal Brexit on Vaccine Supplies

Lord Bassam of Brighton Excerpts

Wednesday 16th December 2020 Lords Chamber

Asked by

[Lord Bassam of Brighton]

To ask Her Majesty’s Government what assessment they have made of the impact on supplies of COVID-19 vaccines to the United Kingdom in the event of the United Kingdom’s departure from the European Union without a deal.

[Lord Bassam of Brighton (Lab) [V]]

My Lords, it is extremely concerning that the Government should contemplate no deal in two weeks’ time, in the middle of a pandemic, with the serious impact this could have on medical supplies and supplies of Covid-19 vaccines. How many Pfizer/BioNTech vaccines will be in the UK by 31 December? How many government ferries and RAF planes are on standby to bring Covid-19 vaccines into the UK in the event of no deal, and at what cost?

[The Parliamentary Under-Secretary of State, Department for Business, Energy and Industrial Strategy (Lord Callanan) (Con)]

I think the noble Lord forgot to ask the main Question: I shall give him the Answer to that first and then go on to his supplementary. The UK has put in place a number of measures to facilitate trade with the EU beyond the end of the transition period and to avoid impact on vaccine supplies beyond 1 January. The Government have worked with Covid-19 vaccine suppliers to support them with robust contingency plans. If necessary, we will use alternative supply routes and Government-procured freight capacity in line with current government advice.

On his supplementary question, the noble Lord will understand that unfortunately I cannot set out details of commercial arrangements relating to vaccines at the present time, but I can reassure him that part of the commercial arrangements with vaccine developers is a requirement to ensure that vaccines are transported safely and securely to minimise the cost of damage.